Skip to content

The efficacy of interval walking training in rehabilitation medicine for mild heart failure patients

The efficacy of interval walking training in rehabilitation medicine for mild heart failure patients - Application of interval walking training to rehabilitation medicine for mild heart failure patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034068
Enrollment
80
Registered
2018-10-01
Start date
2018-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild heart failure

Interventions

Cycling exercise training (30min/day, a day/ week)at the intensity above the anaerobic threshold Cycling exercise training (30min/day, a day/ week) + Interval walking training (30min/day, 3days/ week)

Sponsors

Shinshu University
Lead Sponsor
North Alps Medical Center Azumi Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients who had not increased peak aerobic capacity although they had undergone cycling exerice training 30min/day, a day/ week, for more than 6 months in a hospital. 2) Patients who are classified into level I or II according to the NYHA classification. 3) Patients in whom the left ventricular ejection fraction is less than 60%. 4) Patients in whom plasma Na uretic peptide concentration is more than 18.5 pg/ml. 5) Patients who give an informed consent to voluantarily particopate in the study.

Exclusion criteria

Exclusion criteria: 1) Patients who are classified into the level II or III according to the NYHA classification. 2) Patients whose left ventricular ejection fraction is more than 60% and plasma Na uretic peptide is lower than 18.5pg/ml. 3)Patients whom a primary investigator and/or a cardiologist judge as irrerevant to participate in the study.

Design outcomes

Primary

MeasureTime frame
Peak aerobic capacity

Secondary

MeasureTime frame
Peak heart rate Ventiation threshold Oxygen puslse (O2 pulse) Left ventricular diastolic capacity (E/e') Left ventricular ejection fraction(LVEF) B type Na uretic peptide(BNP)

Countries

Japan

Contacts

Public ContactHiroshi Nose

Shinshu University Graduate School of Medicine

nosehir@shinshu-u.ac.jp0263-37-2681

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026